
Overview
I was drawn to the field of oncology because cancer is a terrifying diagnosis for most people. It is one of those health issues that make people very nervous. I find great satisfaction working with cancer patients to help allay their fears and provide the best care possible. For me, it is rewarding to work with individuals who express so much courage in overcoming a difficult diagnosis. It is very rare that a patient comes alone to an appointment. Usually they have a spouse, son or daughter, a brother or sister, or a mother or father accompanying them. I spend a lot of time answering family member’s questions, who often provide a significant amount of care and support for their loved one. My job is to help educate both the patient and the family and to formulate a plan by which we can provide comprehensive care for all of the patient’s needs.
Dr. Kelsey is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC).
His clinical research consists of co-authoring 36 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2400 Pratt St, Durham, NC 27705
20 Duke Medicine Cir, Durham, NC 27710
20 Duke Medicine Cir, Durham, NC 27710
Additional Areas of Focus
Dr. Kelsey has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Nhcs Physicians Inc
Laura Jacimore is a Radiation Oncologist in Rocky Mount, North Carolina. Dr. Jacimore is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). Her top areas of expertise are Breast Cancer, Angiosarcoma, Laryngeal Cancer, and Prostate Cancer. Dr. Jacimore is currently accepting new patients.
Duke Cancer Center Breast Clinic
My goal is to provide tailored treatment that aligns with the goals and values of each patient. I was initially attracted to radiation oncology by the cutting-edge technology and the inspiring patients I met. It is a privilege to care for patients during potentially one of the most challenging times of their lives. I strive to make patients feel supported during their treatment and reassured that they are receiving the most up-to-date treatments at Duke. When not in the clinic, I enjoy exploring nature, game nights with friends, and relaxing with my husband and cat. Dr. Westergaard is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). Her top areas of expertise are Breast Cancer, Orbital Pseudotumor, Pleuropulmonary Blastoma, and Lung Cancer.
Greensboro Radiation Oncologists PA
James Palermo is a Radiation Oncologist in Greensboro, North Carolina. Dr. Palermo is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Non-Muscle Invasive Bladder Cancer, and Muscle Invasive Bladder Cancer. Dr. Palermo is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Kelsey isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Kelsey isDistinguished. Learn about EGFR Positive Lung Cancer.
- Follicular LymphomaDr. Kelsey isDistinguished. Learn about Follicular Lymphoma.
- Large-Cell Lung CarcinomaDr. Kelsey isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Kelsey isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Kelsey isDistinguished. Learn about Lung Cancer.
- Advanced
- Anaplastic Large Cell LymphomaDr. Kelsey isAdvanced. Learn about Anaplastic Large Cell Lymphoma.
- Classical Hodgkin LymphomaDr. Kelsey isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Hodgkin LymphomaDr. Kelsey isAdvanced. Learn about Hodgkin Lymphoma.
- Lymphomatoid PapulosisDr. Kelsey isAdvanced. Learn about Lymphomatoid Papulosis.
- MesotheliomaDr. Kelsey isAdvanced. Learn about Mesothelioma.
- Metastatic Brain TumorDr. Kelsey isAdvanced. Learn about Metastatic Brain Tumor.
- Experienced
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Kelsey isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Familial Prostate CancerDr. Kelsey isExperienced. Learn about Familial Prostate Cancer.
- Lung NodulesDr. Kelsey isExperienced. Learn about Lung Nodules.
- MelanomaDr. Kelsey isExperienced. Learn about Melanoma.
- Myeloproliferative Neoplasms (MPN)Dr. Kelsey isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

